WHY PEOPLE CHOOSE AMERA
  | Améra | Others |
---|---|---|
Real Results, Not Just Promises | ||
Clinically-Inspired Ingredients | ||
No Fillers, Ever |


Améra Fauxzempic MB-1 Capsules

Journal: Journal of Nutritional Science and Vitaminology 2014
A randomized, single-blind, placebo-controlled, study involving 19 healthy female participants was conducted to examine the effect of daily ingestion of grains of paradise on whole-body energy expenditure and body fat.
Key Findings:
- Supports decreases in visceral fat*
- Supports improved body composition*
- Up to 97 more calories burned per day*
Source: Daily Ingestion of Grains of Paradise (Aframomum melegueta) Extract Increases Whole-Body Energy Expenditure and Decreases Visceral Fat in Humans

Journal of Nutritional Science and Vitaminology 2021
A randomized, single-blind, placebo-controlled study involving healthy male volunteers was conducted over 5 weeks to investigate if grains of paradise might revive brown adipose tissue (BAT) in individuals who have lost active BAT.
Key Findings:
- Supports decreases in body fat %*
- Can elevate adaptive thermogenesis*
- Supports reactivation of brown adipose tissue (BAT)*
Source: Prolonged Treatment with Grains of Paradise (Aframomum melegueta) Extract Recruits Adaptive Thermogenesis and Reduces Body Fat

The Journal of Alternative and Complementary Medicine 2019
A randomized, double-blind, placebo-controlled pilot trial involving 67 subjects aged 25-60 years old, was conducted over 8 weeks to confirm the efficacy of CQR-300 in reducing body fat.
Key Findings:
- Supports decreases in body fat measured by DEXA*
- Supports healthy adiponectin levels, a hormone that regulates fat metabolism*
- Improves cholesterol and triglyceride levels*
Source: The Use of a Stem and Leaf Aqueous Extract of Cissus Quadrangularis (CQR-300) to Reduce Body Fat and Other Components of Metabolic Syndroms in Overweight and obese Participants

Journal: Natural Product Communications (NPC) 2015
A randomized, double-blind, placebo-controlled study involving 61 participants aged 19-55 years old, was conducted over 8 weeks to test the efficacy of CQR-300 in improving metabolic parameters in participants with a BMI>28.
Key Findings:
- Supports improved waist and hip circumference*
- Supports healthy blood pressure and blood sugar levels*
- Supports increases in HDL (good) cholesterol*
- Source: The use of cissus quadrangularis (CQR-300) in the management of components of metabolic syndrome in overweight and obese participants

Lipids in Health and Disease 2006
A randomized, double-blind, placebo-controlled study involving 123 participants aged 19-50 years old, was conducted for 8 weeks to investigate the use of CQR-300 in the management of certain metabolic factors.
Key Findings:
- Supports reductions in body fat % and waist circumference*
- Supports decreases in cholesterol and blood sugar levels*
- Supports reductions in C-reactive protein (inflammatory marker)*
Source: The Use of Cissus Quadrangularis Formulation in the Management of Weight Loss and Metabolic Syndrome

Journal: Lipids in Health and Disease 2007
A double-blind placebo-controlled study involving 168 participants aged 19-50 years old was conducted over 8 weeks to determine the effect of CQR-300 in participants with a BMI>30:
Key Findings:
- Supports reductions in body weight, body fat and cholesterol
- Supports appetite control through an increase in serotonin levels*
- Has antioxidant properties to counter oxidative stress*
Source: The effect of cissus quadrangularis (CQR-300) and a cissus formulation (CORE) on obesity and obesity-induced oxidative stress

Journal: Lipids in Health and Disease 2008
A randomized double-blind placebo-controlled involving 72
participants aged 21-44 years old, was conducted for 10 weeks to evaluate the effects of combining CQR-300 with IGOB131 on weight loss.
Key Findings:
- Supports up to a 20% reduction in body fat*
- Supports up to 31% decrease in blood glucose*
- Supports up to a 44% decrease in total cholesterol*
Source: The use of a cissus quadrangularis/irvingia gabonensis combination in the management of weight loss: double-blind, placebo-controlled

Journal: Functional Foods in Health and Disease 2020
A randomized, placebo controlled, double-blind study involving 32 participants was conducted over 20 weeks to investigate the efficacy of IGOB131's active compound on body fat ratio and triglyceride levels in healthy adults.*
Key Findings:
- Supports visceral and subcutaneous fat loss*
- Supports body weight and body fat ratio reductions*
- Supports reduced triglyceride levels*
Source: Effect of Ellagic Acid on Body Fat and Triglyceride Reduction in Healthy Overweight Volunteers: a
Randomized, Double-blind, Placebo-controlled Parallel Group Study

Journal: Lipids in Health and Disease 2005
A randomized, double-blind, placebo-controlled study involving 40 participants was conducted over 4 weeks to evaluate the efficacy of IGOB131 seeds in the management of metabolic factors.
Key Findings:
- Supports improved waist and hip circumference*
- Supports healthy blood pressure levels*
- Supports a decrease in cholesterol*
Source: The Effect of Irvingia Gabonensis seeds on Body Weight and Blood Lipids of Obese Subjects in Cameroon

Journal: Functional Foods in Health and Disease 2015
A randomized, double-blind, placebo-controlled study involving 48 participants was conducted over 8 weeks to investigate the effects of GOB131 in healthy participants.*
Key Findings:
- Supports a reduction in body weight*
- Supports a reduction in BMI*
- Supports a decrease in cholesterol and triglycerides*
Source: The Effect of Extracts of Irvingia gabonensis (IGOB131) and Dichrostachys glomerata (Dyglomera™) on Body Weight and Lipid Parameters of Healthy Overweight

Journal: EBioMedicine 2016
A randomized, double-blind placebo-controlled study involving 225 participants aged 18-65 years old was conducted over 6 months to investigate the effects of Bifidobacterium animalis ssp. lactis 420 (B420) on body fat mass and other parameters.
Key Findings:
- Supports a decrease in trunk fat mass*
- Supports curbed cravings and a regulated appetite*
- Reduces zonulin levels (marker of disrupted gut barrier function)*
Source: Probiotic With or Without Fiber Controls Body Fat Mass, Associated With Serum Zonulin, in Overweight and Obese Adults-Randomized Controlled Trial

Journal: Beneficial Microbes 2019
A randomized, double-blind, placebo-controlled study involving 134 participants aged 18-65 years old was conducted over 6 months to test if Bifidobacterium animalis ssp. lactis 420 (B420) is associated with changes in gut microbiota.
Key Findings:
- Supports increases in Akkermansia (associated with improved metabolic health)*
- Supports a healthy gut microbiome (increases the ratio of
"good to bad gut bacteria"* - Supports gut barrier function*
Source: Probiotic or Synbiotic Alters the Gut Microbiota and Metabolism in a Randomised Controlled Trial of Weight Management in Overweight Adults

Journal: Nutrients 2020
An analysis of the in vitro, pre-clinical, and clinical studies that have investigated the effects of Bifidobacterium animalis ssp. lactis 420 (B420) was conducted to determine its effects on gut microbiota and metabolic health.
Key Findings:
- Supports improved gut barrier function**
- Supports an improvement in waist to hip ratio*
- Supports improvements in gut dysbiosis*
Source: Bifidobacterium animalis subsp. lactis 420 for Metabolic Health: Review of the Research

Journal: British Journal of Nutrition 2013
A randomized, single-blind, placebo-controlled study involving 19 healthy male participants was conducted to examine the effects of grains of paradise on whole-body energy expenditure and brown adipose tissue (BAT) activity.
Key Findings:
- Supports up to a 5x increase in calories burned over 2 hours*
- Supports increases in metabolic rate within 30 minutes of administration*
- Supports elevated metabolic rate for several hours over baseline*
Source: Grains of paradise (Aframomum melegueta) extract activates brown adipose tissue and increases whole-body energy expenditure in men




